# VYxeoS Liposomal Italian Observational Study iN the Real Practice

> **NCT06143839** · — · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 113 (actual)

## Conditions studied

- Acute Myeloid Leukemia (AML)
- Acute Myeloid Leukemia With Myelodysplasia-Related Changes
- Therapy-Related Acute Myeloid Leukemia

## Interventions

- **DRUG:** Vyxeos liposomal

## Key facts

- **NCT ID:** NCT06143839
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-07
- **Primary completion:** 2025-10-23
- **Final completion:** 2025-10-23
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06143839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06143839, "VYxeoS Liposomal Italian Observational Study iN the Real Practice". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT06143839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*